Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Factoría Bogar was a private Mexican pharmaceutical company focused on pharmaceutical innovation, including highly specialized generics, new medicines, innovative pharmaceutical forms, and import/export of finished pharmaceutical products. The company also operated as a pharmaceutical wholesaler and commercial partner for national and international manufacturers in Mexico. Publicly available information indicates it distributed healthcare products and entered at least one cross-border commercialization agreement with Inmunotek for importation, marketing, and distribution in Mexico. In 2020, its subsidiary PMI collaborated with CURE Pharmaceutical to distribute wellness products in Mexico and to access CUREform-based formulation opportunities. Recent business-directory sources still list the legal entity in Guadalajara, Jalisco, but Crunchbase classifies the company as permanently closed, so current operating status appears inactive or uncertain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Factoría Bogar.